| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.62▼ | 6.59▲ | 6.69▼ | 6.45▲ | 5.76▲ |
| MA10 | 6.58▲ | 6.59▲ | 6.48▲ | 6.05▲ | 5.77▲ |
| MA20 | 6.61▼ | 6.48▲ | 6.49▲ | 5.80▲ | 5.56▲ |
| MA50 | 6.51▲ | 6.17▲ | 6.04▲ | 5.79▲ | 4.37▲ |
| MA100 | 6.25▲ | 5.88▲ | 5.89▲ | 5.58▲ | N/A |
| MA200 | 5.93▲ | 5.88▲ | 5.82▲ | 4.62▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | -0.001▼ | 0.110▲ | -0.016▼ |
| RSI | 52.406▲ | 55.712▲ | 56.669▲ | 61.120▲ | 70.836▲ |
| STOCH | 62.968 | 51.039 | 59.279 | 72.442 | 34.186 |
| WILL %R | -50.000 | -51.408 | -42.197 | -29.166 | -29.302 |
| CCI | 11.100 | 37.497 | 47.316 | 127.793▲ | 171.730▲ |
|
Thursday, November 13, 2025 02:12 PM
The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported from Cohort 5; ...
|
|
Friday, November 07, 2025 02:17 AM
Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-T) from The Globe and Mail including charting and trades.
|
|
Thursday, October 30, 2025 04:52 AM
Analyst Douglas Loe said the Victoria, B.C.-based biotechnology company’s proprietary drug-delivery platform positions it to “innovate meaningfully in autoimmune and inflammatory disease markets,” led ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 6.41 | 7.0994 | 6.1501 | 6.56 | 173,640 |
| 13/11/25 | 6.52 | 6.55 | 6.035 | 6.34 | 154,884 |
| 12/11/25 | 6.64 | 6.74 | 6.47 | 6.60 | 76,984 |
| 11/11/25 | 6.14 | 6.74 | 6.02 | 6.53 | 140,895 |
| 10/11/25 | 5.57 | 6.325 | 5.57 | 6.23 | 199,800 |
| 07/11/25 | 5.575 | 5.58 | 5.29 | 5.45 | 42,360 |
| 06/11/25 | 5.67 | 5.69 | 5.25 | 5.575 | 67,985 |
| 05/11/25 | 5.46 | 5.785 | 5.39 | 5.67 | 480,929 |
| 04/11/25 | 6.12 | 6.12 | 5.35 | 5.45 | 37,828 |
| 03/11/25 | 5.69 | 6.10 | 5.47 | 6.09 | 313,580 |
|
|
||||
|
|
||||
|
|